Skip to main content
JUSHF
OTC Life Sciences

Shareholders to Vote on Redomiciling to Nevada, Restructuring Capital

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
8
Price
$0.52
Mkt Cap
$103.842M
52W Low
$0.265
52W High
$0.98
Market data snapshot near publication time

summarizeSummary

Jushi Holdings Inc. filed a definitive proxy statement for a shareholder meeting on June 24, 2026, to vote on redomiciling to Nevada, USA, and restructuring its authorized capital, a move aimed at improving US capital market access.


check_boxKey Events

  • Proposed Redomiciliation to Nevada

    Shareholders will vote on a special resolution to change the company's legal domicile from British Columbia, Canada, to Nevada, USA, to better align with its US-centric operations and strategic objectives.

  • Shareholder Meeting Scheduled

    The annual general and special meeting of shareholders is set for June 24, 2026, where the redomiciliation and other governance matters will be considered.

  • Capital Structure Restructuring

    The authorized capital will be amended to consist of 2 billion shares of Nevada Common Stock and 1 billion shares of undesignated Nevada Preferred Stock, replacing the current unlimited share structure. Existing shares, options, and warrants will convert 1:1 without dilution.

  • Strategic Benefits Highlighted

    The company anticipates enhanced acceptance in US capital markets, improved stock marketability, and potential for easier listing on a major US exchange, along with streamlined regulatory interactions and access to additional funding sources.


auto_awesomeAnalysis

Jushi Holdings Inc. is seeking shareholder approval to redomicile from British Columbia, Canada, to Nevada, USA. This strategic move aims to align the company's legal structure with its US-based operations, enhance access to US capital markets, and potentially facilitate a future listing on a major US stock exchange if cannabis regulations evolve. The proposal includes a significant restructuring of the authorized share capital from unlimited shares to a fixed 2 billion common shares and 1 billion preferred shares, while ensuring no immediate dilution for existing shareholders. This definitive proxy statement sets the stage for a critical vote on the company's long-term strategic direction and capital structure.

At the time of this filing, JUSHF was trading at $0.52 on OTC in the Life Sciences sector, with a market capitalization of approximately $103.8M. The 52-week trading range was $0.27 to $0.98. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed JUSHF - Latest Insights

JUSHF
May 11, 2026, 4:07 PM EDT
Filing Type: DEF 14A
Importance Score:
8
JUSHF
Apr 24, 2026, 8:30 AM EDT
Filing Type: DEFA14A
Importance Score:
7
JUSHF
Mar 31, 2026, 4:28 PM EDT
Filing Type: 10-K
Importance Score:
8
JUSHF
Mar 31, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
JUSHF
Jan 06, 2026, 4:20 PM EST
Filing Type: 8-K
Importance Score:
8